LidoSite FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved May 10, 2004)
Brand name: LidoSite
Generic name: lidocaine and Epinephrine
Dosage form: Topical System
Company: Vyteris, Inc.
Treatment for: Local Anesthesia
LidoSite (lidocaine and epinephrine) is an iontophoretic delivery system providing local analgesia prior to the administration of superficial dermatological procedures.
Development timeline for LidoSite
| Date | Article |
|---|---|
| May 10, 2004 | Approval LidoSite Vyteris, Inc. - Treatment for Localized Pain |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
